Legend Biotech Corp. (LEGN)
22.17
-0.15
(-0.67%)
USD |
NASDAQ |
Dec 15, 15:05
Legend Biotech EPS Diluted (Quarterly): -0.2152 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| Exelixis, Inc. | 0.695 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Akero Therapeutics, Inc. | -0.9946 |
| Cabaletta Bio, Inc. | -0.4387 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -39.74M |
| Revenue (Quarterly) | 272.69M |
| Total Expenses (Quarterly) | 312.43M |
| Enterprise Value | 3.537B |
| Gross Profit Margin (Quarterly) | 55.42% |
| Profit Margin (Quarterly) | -14.57% |
| Earnings Yield | -5.89% |
| Normalized Earnings Yield | -5.870 |